RxDoctor Payments Data

Karen Kadish, NP

Nurse Practitioner · Portsmouth, NHNPI 1386633733

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $1,200 of the $1,738 with a category attached, or 69.0%. Bristol Myers Squibb accounts for 69.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $1,378 and has fallen 92.6% since, to $102 in 2025. Among nurse practitioner clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,738in general payments, 2019–2025

Across 17 payments — averaging $102.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$1K
  • AbbVie$135
  • Ipsen Biopharmaceuticals, Inc$114
  • Epizyme, Inc.$91
  • Pharmacyclics LLC, An Abbvie Company$82
  • Johnson & Johnson$63
  • plus $53 from 2 others

What the payments were for

  • Speaking & faculty fees$1,20069%
  • Food & beverage$53831%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,738 in reported general payments places this provider in the 95th percentile of 714 nurse practitioner providers in New Hampshire.

See all nurse practitioner providers in New Hampshire

Medicare billing

Part B allowed, 2024
$6,179
Medicare patients
50
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Portsmouth

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →